Date published: 2026-9-2

1-800-457-3801

SCBT Portrait Logo
Seach Input

DDX21 Inhibitors

DDX21 inhibitors belong to a distinctive class of chemical compounds that target the DDX21 protein, a member of the DEAD-box RNA helicase family. The DDX21 protein is a multifunctional RNA helicase that plays a crucial role in various cellular processes, particularly in the regulation of RNA metabolism and processing. As an ATP-dependent helicase, DDX21 unwinds RNA duplexes and facilitates the remodeling of RNA-protein complexes, thereby influencing the overall landscape of cellular RNA dynamics.

DDX21 inhibitors are designed to selectively interact with the catalytic domains of the DDX21 protein, disrupting its helicase activity and impeding its ability to modulate RNA structures. These inhibitors often feature specific chemical moieties that bind to key residues within the active site of the protein, preventing ATP binding and subsequent unwinding of RNA molecules. By hindering the function of DDX21, these inhibitors aim to elucidate the intricate roles played by the protein in RNA-related cellular processes, offering valuable insights into fundamental molecular mechanisms. The development and study of DDX21 inhibitors contribute to a deeper understanding of RNA helicase function and may pave the way for the discovery of novel compounds that could serve as tools for basic research in molecular biology.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Flavopiridol

146426-40-6sc-202157
sc-202157A
5 mg
25 mg
$78.00
$259.00
41
(3)

A cyclin-dependent kinase inhibitor that can disrupt cell cycle progression, potentially affecting the cellular processes that DDX21 is involved in.

Geldanamycin

30562-34-6sc-200617B
sc-200617C
sc-200617
sc-200617A
100 µg
500 µg
1 mg
5 mg
$39.00
$59.00
$104.00
$206.00
8
(1)

An Hsp90 inhibitor that can destabilize various client proteins, possibly influencing the protein folding and maturation pathways associated with DDX21.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

A PI3K inhibitor that can alter signaling pathways, which may indirectly affect the functions of RNA helicases like DDX21.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

A p38 MAP kinase inhibitor that might modulate stress response pathways and thus indirectly affect DDX21 activity.

17-AAG

75747-14-7sc-200641
sc-200641A
1 mg
5 mg
$67.00
$156.00
16
(2)

Another Hsp90 inhibitor similar to Geldanamycin, which can affect the stability and function of associated proteins.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

An mTOR inhibitor that could affect the translation of proteins and potentially impact DDX21's role in RNA metabolism.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

A proteasome inhibitor that can affect the degradation of proteins, potentially affecting DDX21-involved pathways.

Olaparib

763113-22-0sc-302017
sc-302017A
sc-302017B
250 mg
500 mg
1 g
$210.00
$305.00
$495.00
10
(1)

A PARP inhibitor that can affect DNA repair processes, which might indirectly influence DDX21 functions.

ATM Kinase Inhibitor

587871-26-9sc-202963
2 mg
$110.00
28
(2)

An ATM inhibitor that can impact DNA damage response, potentially affecting DDX21's involvement in ribosome biogenesis.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

A JNK inhibitor that might alter stress response and apoptosis pathways, potentially influencing DDX21 activity.